Sagar Lonial
MD
Chief Medical Officer and Executive Vice President for Medical Affairs
👥Biography 个人简介
Sagar Lonial is a key opinion leader in myeloma therapeutics with deep expertise in bispecific antibody development. He has contributed to clinical trials of teclistamab, talquetamab, and other bispecific platforms targeting BCMA, GPRC5D, and FcRH5. His research on optimal sequencing of bispecifics and CAR-T cells informs clinical practice worldwide.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Sagar Lonial 的研究动态
Follow Sagar Lonial's research updates
留下邮箱，当我们发布与 Sagar Lonial（Emory University Winship Cancer Institute）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment